LOOMIS SAYLES & CO L P - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 72 filers reported holding UTAH MED PRODS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LOOMIS SAYLES & CO L P ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$3,959
-15.4%
46,028
-8.3%
0.01%
-12.5%
Q2 2023$4,677
-4.2%
50,182
-2.6%
0.01%0.0%
Q1 2023$4,883
-7.3%
51,520
-1.7%
0.01%
-27.3%
Q4 2022$5,269
-99.9%
52,404
-0.9%
0.01%
+22.2%
Q3 2022$4,509,000
-10.1%
52,854
-9.5%
0.01%0.0%
Q2 2022$5,016,000
-5.0%
58,402
-0.6%
0.01%
+28.6%
Q1 2022$5,280,000
-12.9%
58,756
-3.1%
0.01%0.0%
Q4 2021$6,061,000
+6.1%
60,613
-1.5%
0.01%0.0%
Q3 2021$5,714,000
+9.0%
61,548
-0.2%
0.01%
+16.7%
Q2 2021$5,244,000
+50.0%
61,672
+52.8%
0.01%
+20.0%
Q1 2021$3,496,000
-2.2%
40,370
-4.7%
0.01%0.0%
Q4 2020$3,573,000
+3.5%
42,377
-1.9%
0.01%0.0%
Q3 2020$3,452,000
+3.3%
43,215
+14.6%
0.01%0.0%
Q2 2020$3,343,000
+10.5%
37,717
+17.2%
0.01%
-16.7%
Q1 2020$3,025,000
-44.5%
32,172
-36.3%
0.01%
-33.3%
Q4 2019$5,449,000
+6.2%
50,506
-5.7%
0.01%
-10.0%
Q3 2019$5,131,000
-12.8%
53,541
-12.9%
0.01%
-9.1%
Q2 2019$5,883,000
+4.4%
61,473
-3.7%
0.01%0.0%
Q1 2019$5,635,000
+7.3%
63,854
+1.0%
0.01%
-8.3%
Q4 2018$5,254,000
-3.9%
63,251
+9.0%
0.01%
+9.1%
Q3 2018$5,468,00058,0460.01%
Other shareholders
UTAH MED PRODS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Clean Yield Group 49,094$3,535,0001.48%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 27,464$1,988,0000.72%
Ativo Capital Management LLC 16,525$1,196,0000.33%
Ancora Advisors LLC 55,159$3,993,0000.26%
ISTHMUS PARTNERS, LLC 10,754$779,0000.23%
Cardinal Capital Management 9,180$665,0000.22%
Acrospire Investment Management LLC 1,919$139,0000.13%
Penobscot Investment Management Company, Inc. 4,000$290,0000.09%
TFS CAPITAL LLC 3,226$234,0000.09%
WCM INVESTMENT MANAGEMENT, LLC 81,912$5,930,0000.09%
View complete list of UTAH MED PRODS INC shareholders